INSIGHTS ON DRUG DEVELOPMENT

• VEGF Signaling Pathway

  In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

• The QX700: Advanced Digital PCR System

  Advanced digital PCR workflows provide precise, standard-free quantification. Maximize insights from small samples with seven-target multiplexing and automated steps to ensure high-throughput accuracy.

• Functional Characterization Of 3D Assembled Neurospheres

  Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

• Optical Microscopy For Process Monitoring And Product Characterization

  Modern optical microscopy reveals cellular activity and material quality with exceptional clarity. See how tailored, feature‑rich imaging systems help researchers generate high‑value data.

• From 51% Yield To 87% With Targeted Impurity Removal

  5/7/2026

  Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.

• Get More From Less: AMP Chemistry Outperforms Hybrid Capture

  6/9/2026

  Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.

• Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development

  3/3/2026

  Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.

• From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development

  3/8/2026

  See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

• Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration

  8/20/2025

  Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.